Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Stakeholders say some compounded veterinary drugs are unavailable in California after Board of Pharmacy rule changes
Summary
Board members and stakeholders reported that recent Board of Pharmacy compounding regulations and interpretations have made several equine ophthalmic medications unavailable in California; board staff convened a joint stakeholder meeting with the Board of Pharmacy to explore solutions
Stakeholders told the California Veterinary Medical Board on Oct. 22 that a recent Board of Pharmacy rulemaking and enforcement interpretation has made a small number of compounded veterinary drugs unavailable in California, and participants described ongoing talks to find interim and longer-term fixes.
Why it matters: veterinarians said the affected products include drugs used for equine ophthalmic care. For veterinarians treating horses and some exotic species, the absence of these compounded preparations could constrain clinical options.
What stakeholders reported
At a joint stakeholder meeting convened Oct. 1 by the Veterinary Medical Board and the Board of Pharmacy, attendees identified multiple potential causes for limited availability of…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
